"For over two decades, CIT has been dedicated to assisting pharmaceutical companies find new cures to help patients better manage their healthcare."

During the past decade, CITrials conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 9 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CITrials" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Forest Laboratories" with 2 trials sponsored, "Karuna Therapeutics" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CITrials" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Neumora Therapeutics, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CITrials" are "Schizophrenia" (8 trials), "Alzheimer's Disease" (4 trials), "Bipolar I Disorder" (3 trials), "Major Depressive Disorder" (3 trials) and "Schizophrenia, Schizoaffective Disorder" (2 trials). Many other conditions were trialed in "CITrials" in a lesser frequency.

Most popular intervention types in "CITrials" are "Drug" (23 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Brexpiprazole" (2 trials), "RO6889450" (2 trials), "TAK-994" (2 trials) and "Vilazodone" (2 trials). Other intervention names were less common.

The vast majority of trials in "CITrials" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CITrials". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in CITrials, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CITrials, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".